Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Yukio Tsurumi"'
Autor:
Haruki Sekiguchi, Yoichi Ajiro, Yoshie Uchida, Kentaro Jujo, Kazunori Iwade, Naohide Tanaka, Ken Shimamoto, Yukio Tsurumi, Masatoshi Kawana, Nobuhisa Hagiwara
Publikováno v:
Kidney International Reports, Vol 3, Iss 1, Pp 65-72 (2018)
Contrast-induced nephropathy is a complication following coronary angiography and percutaneous coronary intervention. Because contrast-induced nephropathy is a predictor of long-term mortality in patients with ischemic heart disease undergoing percut
Externí odkaz:
https://doaj.org/article/c702ea1ed6b744a494ae71326b398a52
Autor:
Nobuhisa Hagiwara, Haruki Sekiguchi, Yoichi Ajiro, Yukio Tsurumi, Naohide Tanaka, Kazunori Iwade, Kentaro Jujo, Ken Shimamoto, Masatoshi Kawana, Yoshie Uchida
Publikováno v:
Kidney International Reports, Vol 3, Iss 1, Pp 65-72 (2018)
Kidney International Reports
Kidney International Reports
Introduction Contrast-induced nephropathy is a complication following coronary angiography and percutaneous coronary intervention. Because contrast-induced nephropathy is a predictor of long-term mortality in patients with ischemic heart disease unde
Autor:
Yukio Tsurumi, Atsushi Honda, Kentaro Jujo, Noritoshi Fukushima, Nobuhisa Hagiwara, Dai Yumino, Keiko Fukushima, Masatoshi Kawana, Haruki Sekiguchi
Publikováno v:
Journal of Interventional Cardiology. 27:252-259
Objective To determine whether adequate myocardial perfusion status after transluminal recanalization is associated with prompt improvement of QT dispersion (QTd). Background Transluminal recanalization of the infarct-related coronary artery in acute
Autor:
Nobuhisa Hagiwara, Yukio Tsurumi, Katsuhisa Matsuura, Atsushi Honda, Noritoshi Fukushima, Hiroshi Kasanuki
Publikováno v:
Atherosclerosis. 205:376-384
Objective Although recent clinical trials have suggested that angiotensin II type 1 receptor blockers (ARBs) reduced cardiovascular events, the precise mechanisms involved are still unknown. Telmisartan, an ARB, has recently been identified as a liga
Publikováno v:
Circulation Journal. 72:179-185
BACKGROUND: Outcomes after percutaneous coronary intervention (PCI) for patients with acute myocardial infarction (AMI) complicated by renal insufficiency have not been well described. The aims of this study were to evaluate the association of estima
Autor:
Motoko Hosaka, Nobuhisa Hagiwara, Atsushi Takagi, Kazue Gunnji, Naoko Ishizuka, Yuki Komatsu, Kotaro Arai, Yukio Tsurumi, Kyomi Tanimoto
Publikováno v:
Circulation Journal. 72:1640-1644
Background In the present study it was examined whether transthoracic Doppler echocardiography (TTDE) would be useful for noninvasive diagnosis of coronary spastic angina (CSA) by assessing coronary arterial tone in the morning. Methods and Results T
Autor:
Ryo Koyanagi, Nobuhisa Hagiwara, Hiroshi Kasanuki, Yukio Tsurumi, Hiroshi Ogawa, null on behalf of the HIJAMI investigators
Publikováno v:
Circulation Journal. 72:1391-1396
Background Because there is insufficient evidence to support primary percutaneous coronary intervention (PPCI) as the treatment of acute myocardial infarction (AMI), this study elucidated the efficacy of PPCI according to disease severity. Methods an
Publikováno v:
The American Journal of Cardiology. 99:26-30
There has been growing evidence associating obstructive sleep apnea (OSA) with cardiovascular pathogenesis. We hypothesized that OSA may affect outcomes after percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). We
Autor:
Yasuko Tomizawa, Hiroshi Kasanuki, Makoto Nakazawa, Masatoshi Kawana, Yukio Tsurumi, Masahiro Endo, Shigeyuki Aomi, Hiroshi Nishida
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 125:570-577
Background: Takayasu arteritis is associated with a low incidence of coronary artery involvement, such as stenosis, obstruction, aneurysm, and coronary steal syndrome, but coronary ischemia can be fatal. Methods: Between 1972 and April 2001, 81 of 13
Autor:
Atsushi Takagi, Hiroshi Kasanuki, Masatoshi Kawana, Hirotaka Nagashima, Naoko Ishizuka, Hisako Omori, Nobuhisa Hagiwara, Yukio Tsurumi
Publikováno v:
British Journal of Clinical Pharmacology. 54:395-399
Aims HMG-CoA reductase inhibitors (statins) have been demonstrated to have in vitro vascular effects. The aim of this study was to determine whether statins actually have in vivo vascular effects independent of their cholesterol-lowering effect.